Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us
Publications

Roundtable on sustaining access to liquid medical oxygen in LMICs – Meeting Summary

On 13 October 2022, the Access to Medicine Foundation, in partnership with Chatham House, convened a roundtable to identify solutions for sustaining long-term access to liquid medical oxygen (LOX) in low- and middle-income countries (LMICs). The discussion has been captured in a meeting summary, which is now available for download.

Date

12 December 2022

Download the Meeting Summary

Participants included representatives from medical gas and pharmaceutical companies, global health organisations, investors and other industry experts. 

The roundtable was held under the Chatham House Rule, in order to encourage a free and open exchange of ideas. It was moderated by the Foundation’s CEO, Jayasree K. Iyer.  

Points of discussion: 

  1. The role of medical gas companies, global health agencies and funders in expanding access to LOX in LMICs. 

  1. Concrete actions that medical gas companies and global health partners can take to ensure sustainable access to LOX in LMICs. 

  1. Models that pharmaceutical companies apply to increase access that might be useful for medical gas companies to emulate. 

Takeaways from the discussion: eight key opportunities identified by the Access to Medicine Foundation

Read more

Key takeaways: 

The discussion covered a breadth of issues relating to sustainable access to LOX in LMICs, with participants proposing multiple long-term solutions. There were several common themes throughout the discussion, most notably: 

  1. Continued public-private cooperation;  

  1. Information sharing and transparency; 

  1. Country-led prioritisation and planning.

Marijn Verhoef

Director of Operations/ Interim Director of Government Engagement & Policy

mverhoef@accesstomedicinefoundation.org

Get in touch

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved